Indo Us Biotech (INDOUS)₹66.55−1.60%Other Agricultural Products
Indo Us Biotech is compared with the 10 closest in size in Other Agricultural Products (91 companies in the industry). It has a P/E of 10.2 against a peer median of 10.2, and ROCE of 14.0% against a peer median of 10.0%, and latest-quarter sales growth of −22.0% against a peer median of 19.4%. By market cap it is #6 of 11 in this set.
As of · Peer set: 10 closest in size in Other Agricultural Products
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Annvrridhhi Ventures | 157 | 323.7 | 5.8 | 5.0 | 0.69 | 0.0 | 100 | 1 | 118.8 | 143.3 | vs INDOUS |
| Mangalam Seeds | 155 | 11.2 | 10.0 | 9.7 | 0.55 | 0.0 | 112 | 8 | 25.8 | 1.8 | vs INDOUS |
| Mangalam Seeds | 152 | 10.9 | 10.0 | 9.8 | 0.56 | 0.0 | 112 | 8 | 25.8 | 1.8 | vs INDOUS |
| Harshdeep Hortico | 145 | 11.6 | 29.1 | 23.2 | 0.06 | 0.0 | 69 | 13 | 16.0 | 40.1 | vs INDOUS |
| Puretrop Fruits | 142 | 9.7 | 8.0 | 5.8 | 0.01 | 0.0 | 122 | 25 | 0.5 | −70.1 | vs INDOUS |
| Indo Us Biotech | 134 | 10.2 | 14.0 | 15.2 | 0.40 | 0.0 | 110 | 13 | −22.0 | −46.9 | — |
| TBI Corn | 128 | 6.8 | 18.0 | 16.8 | 0.59 | 0.0 | 304 | 19 | 41.7 | 33.7 | vs INDOUS |
| JK Agri Genetics | 124 | — | 5.0 | −8.1 | 0.00 | 0.0 | 158 | −7 | −8.7 | −8.3 | vs INDOUS |
| City Crops Agro | 120 | — | −13.1 | −13.2 | 0.00 | 0.0 | 19 | −4 | −52.1 | 53.2 | vs INDOUS |
| Kohinoor Foods | 106 | 1.2 | −1.0 | — | — | 0.0 | 148 | 81 | 81.8 | — | vs INDOUS |
| ShreeOswal Seeds and Chemicals | 105 | 8.8 | 19.9 | 15.1 | 0.12 | 0.0 | 247 | 7 | 19.4 | 71.4 | vs INDOUS |
| Peer median | 134 | 10.2 | 10.0 | 9.8 | 0.26 | 0.0 | 112 | 8 | 19.4 | 17.8 |
Listed companies closest to Indo Us Biotech in Other Agricultural Products include Annvrridhhi Ventures, Mangalam Seeds, Mangalam Seeds, Harshdeep Hortico, Puretrop Fruits, TBI Corn, JK Agri Genetics, City Crops Agro.
Annvrridhhi Ventures, with a market cap of ₹157 Cr.
Indo Us Biotech trades at a P/E of 10.2; the median of its peer set is 10.2. A P/E above or below the median is a description, not a judgement on value.
Indo Us Biotech's return on capital employed is 14.0%, above the peer median of 10.0%.